Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05359848 · ClinicalTrials.gov registry record · NA

A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy

A NA study of Medical Oncology and Integrative Oncology, sponsored by State University of New York at Buffalo.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
2
Study locations

NCT05359848 is a NA study of Medical Oncology and Integrative Oncology that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 30 participants, below the 253-participant average among 3 other Medical Oncology trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05359848, a NA study of Medical Oncology and Integrative Oncology, is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

Caloric restriction may alter the response to chemotherapy induced stress response and enhance its antitumor effect. This study intends to use an intermitted caloric restriction protocol with alternate days before the chemotherapy administration to enhance the cytotoxic effect generated by standard treatment of cancer.

Interventions

  • OTHER Diet

Study Locations (2)

New York

  • University at Buffalo / Great Lakes Cancer Care - Buffalo
  • University at Buffalo / Great Lakes Cancer Care - Buffalo

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-04-15
Est. Completion 2027-06-01
Phase NA

What the Registry Record Tells You About NCT05359848

The ClinicalTrials.gov registry entry for NCT05359848 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 253-participant average among 3 other Medical Oncology trials with a reported enrollment target (88% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Medical Oncology appearing as the primary indexed condition, and to 1 intervention - of which Diet is the first listed.

NCT05359848 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05359848 about?

NCT05359848 is a clinical study titled "A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy". Caloric restriction may alter the response to chemotherapy induced stress response and enhance its antitumor effect. This study intends to use an intermitted caloric restriction protocol with alternate days before the chemotherapy administration to enhance the cytotoxic effect generated by standard ...

What is the current status of trial NCT05359848?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-04-15. Estimated completion is 2027-06-01.

What conditions does trial NCT05359848 study?

This clinical trial studies the following conditions: Medical Oncology, Integrative Oncology, Medical Nutrition Therapy.

What interventions are being tested in trial NCT05359848?

The interventions under investigation include: Diet (OTHER).

Who is sponsoring clinical trial NCT05359848?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05359848 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Medical Oncology

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.